The insulin biosimilars market is projected to double by 2033, driven by new partnerships, production facilities, and growing demand for affordable diabetes therapies. https://www.einpresswire.com/article/833971141/insulin-biosimilars-market-set-to-double-by-2033-led-by-novel-partnerships-and-facility-expansions